To compare treatment with insulin-like growth factor-1 to no treatment or placebo for the prevention of retinopathy of prematurity or treatment of early retinopathy of prematurity.
This is a protocol.
Insulin-like growth factor-1 for the prevention or treatment of retinopathy of prematurity
You may also be interested in:
- Treatment with the growth factor, recombinant human insulin-like growth factor I, for amyotrophic lateral sclerosis (motor neuron disease)
- Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
- D-Penicillamine for preventing retinopathy of prematurity in preterm infants
- Beta-blockers for prevention and treatment of retinopathy of prematurity
- Injections of anti-vascular endothelial growth factor for advanced diabetic retinopathy